243 related articles for article (PubMed ID: 21908614)
1. Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A.
Ward RJ; Pediani JD; Milligan G
J Biol Chem; 2011 Oct; 286(43):37414-28. PubMed ID: 21908614
[TBL] [Abstract][Full Text] [Related]
2. Ligand-induced internalization of the orexin OX(1) and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.
Ward RJ; Pediani JD; Milligan G
Br J Pharmacol; 2011 Mar; 162(6):1439-52. PubMed ID: 21175569
[TBL] [Abstract][Full Text] [Related]
3. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.
Xu TR; Ward RJ; Pediani JD; Milligan G
J Biol Chem; 2012 Apr; 287(18):14937-49. PubMed ID: 22389503
[TBL] [Abstract][Full Text] [Related]
4. The orexin OX(1) receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands.
Xu TR; Ward RJ; Pediani JD; Milligan G
Biochem J; 2011 Oct; 439(1):171-83. PubMed ID: 21770891
[TBL] [Abstract][Full Text] [Related]
5. Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep.
Mieda M; Hasegawa E; Kisanuki YY; Sinton CM; Yanagisawa M; Sakurai T
J Neurosci; 2011 Apr; 31(17):6518-26. PubMed ID: 21525292
[TBL] [Abstract][Full Text] [Related]
6. Orexin receptor subtype activation and locomotor behaviour in the rat.
Samson WK; Bagley SL; Ferguson AV; White MM
Acta Physiol (Oxf); 2010 Mar; 198(3):313-24. PubMed ID: 19889100
[TBL] [Abstract][Full Text] [Related]
7. Dynein light chain Tctex-type 1 modulates orexin signaling through its interaction with orexin 1 receptor.
Duguay D; Bélanger-Nelson E; Mongrain V; Beben A; Khatchadourian A; Cermakian N
PLoS One; 2011; 6(10):e26430. PubMed ID: 22028875
[TBL] [Abstract][Full Text] [Related]
8. Autocrine endocannabinoid signaling through CB1 receptors potentiates OX1 orexin receptor signaling.
Jäntti MH; Putula J; Turunen PM; Näsman J; Reijonen S; Lindqvist C; Kukkonen JP
Mol Pharmacol; 2013 Mar; 83(3):621-32. PubMed ID: 23233488
[TBL] [Abstract][Full Text] [Related]
9. Orexins excite neurons of the rat cerebellar nucleus interpositus via orexin 2 receptors in vitro.
Yu L; Zhang XY; Zhang J; Zhu JN; Wang JJ
Cerebellum; 2010 Mar; 9(1):88-95. PubMed ID: 19921532
[TBL] [Abstract][Full Text] [Related]
10. Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor.
Voisin T; Firar AE; Avondo V; Laburthe M
Endocrinology; 2006 Oct; 147(10):4977-84. PubMed ID: 16857748
[TBL] [Abstract][Full Text] [Related]
11. Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells.
Wenzel J; Grabinski N; Knopp CA; Dendorfer A; Ramanjaneya M; Randeva HS; Ehrhart-Bornstein M; Dominiak P; Jöhren O
Am J Physiol Regul Integr Comp Physiol; 2009 Nov; 297(5):R1601-9. PubMed ID: 19793950
[TBL] [Abstract][Full Text] [Related]
12. Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function.
Ellis J; Pediani JD; Canals M; Milasta S; Milligan G
J Biol Chem; 2006 Dec; 281(50):38812-24. PubMed ID: 17015451
[TBL] [Abstract][Full Text] [Related]
13. A role for PKD1 and PKD3 activation in modulation of calcium oscillations induced by orexin receptor 1 stimulation.
Peltonen HM; Akerman KE; Bart G
Biochim Biophys Acta; 2010 Oct; 1803(10):1206-12. PubMed ID: 20621130
[TBL] [Abstract][Full Text] [Related]
14. Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation.
Silveyra P; Lux-Lantos V; Libertun C
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E977-85. PubMed ID: 17638707
[TBL] [Abstract][Full Text] [Related]
15. The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors.
Smart D; Jerman JC; Brough SJ; Neville WA; Jewitt F; Porter RA
Br J Pharmacol; 2000 Apr; 129(7):1289-91. PubMed ID: 10742282
[TBL] [Abstract][Full Text] [Related]
16. [Receptors for oreksins: structure, localisation and activation mechanisms].
Abramova TV; Perekrest SV; Shainidze KZ; Novikova NS; Korneva EA
Ross Fiziol Zh Im I M Sechenova; 2011 Sep; 97(9):995-1007. PubMed ID: 22165210
[TBL] [Abstract][Full Text] [Related]
17. Orexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures.
Urbańska A; Sokołowska P; Woldan-Tambor A; Biegańska K; Brix B; Jöhren O; Namiecińska M; Zawilska JB
J Mol Neurosci; 2012 Jan; 46(1):10-7. PubMed ID: 21547533
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor.
Malherbe P; Borroni E; Gobbi L; Knust H; Nettekoven M; Pinard E; Roche O; Rogers-Evans M; Wettstein JG; Moreau JL
Br J Pharmacol; 2009 Apr; 156(8):1326-41. PubMed ID: 19751316
[TBL] [Abstract][Full Text] [Related]
19. Orexins promote survival of rat cortical neurons.
Sokołowska P; Urbańska A; Namiecińska M; Biegańska K; Zawilska JB
Neurosci Lett; 2012 Jan; 506(2):303-6. PubMed ID: 22138089
[TBL] [Abstract][Full Text] [Related]
20. Activation of orexin/hypocretin type 1 receptors stimulates cAMP synthesis in primary cultures of rat astrocytes.
Woldan-Tambor A; Biegańska K; Wiktorowska-Owczarek A; Zawilska JB
Pharmacol Rep; 2011; 63(3):717-23. PubMed ID: 21857082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
